Last updated at 28 Jan 2025 01:08 PM
Director
DIN: 09238857
Ashish Avinash Rode is currently associated with 4 companies in various capacities such as Designated Partner and Director. They serve as a Director at RADIOVISION DIAGNOSTIC LAB AUNDH LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09238857.Ashish Avinash Rode has previously been associated with 1 company in roles such as Partner.Ashish Avinash Rode is currently involved in 2 different roles. Their most recent position is with VOLARE PHARMACEUTICAL LLP as a Designated Partner. The first company Ashish Avinash Rode was appointed to as a director was RADIOVISION DIAGNOSTIC LAB AUNDH LLP. Ashish Avinash Rode is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ashish Avinash Rode is currently associated with 4 companies in various capacities such as Designated Partner and Director. They serve as a Director at RADIOVISION DIAGNOSTIC LAB AUNDH LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09238857.Ashish Avinash Rode has previously been associated with 1 company in roles such as Partner.Ashish Avinash Rode is currently involved in 2 different roles. Their most recent position is with VOLARE PHARMACEUTICAL LLP as a Designated Partner. The first company Ashish Avinash Rode was appointed to as a director was RADIOVISION DIAGNOSTIC LAB AUNDH LLP. Ashish Avinash Rode is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (3)
Past Companies (1)
1y 4m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RADIOVISION DIAGNOSTIC CENTRE PRIVATE LIMITED | Director | 09-Oct-2023 |